JA
Background
CFO at Cantor Pharma, where I lead finance, corporate development and investor relations for a clinical-stage oncology programme. Previously CFO at Ridgeline Bio through its Series A, and before that ran strategy and corp dev at Pendragon Bio and Halcyon Therapeutics. I started my career in healthcare investment bankin…
Experience24 yrsCompanies8
Career History
Feb 2023 – Present3 yr 9 moChief Financial Officer at Cantor PharmaLondon, England, United Kingdom
Series A → Series B11–50 FTEs£80M Series B
Joined Cantor Pharma at Series A → Series B stage, a team of 11–50 FTEs.
Apr 2019 – Jan 20233 yr 9 moChief Financial Officer at Ridgeline BioLondon, England, United Kingdom
Series A → Series B51–200 → 201–500 FTEs$91.3M Series B
Joined Ridgeline Bio at Series A → Series B stage, a team of 51–200 → 201–500 FTEs.
Jan 2018 – Jan 20191 yrVice President Finance And Corporate Development at Halcyon TherapeuticsLondon, England, United Kingdom
Jan 2013 – Jan 20174 yrSenior Vice President Strategy And Corporate Development at Pendragon BioLondon, England, United Kingdom
Series C → Series D+51–200 FTEs$70M Series D · $15M Series D
Joined Pendragon Bio at Series C → Series D+ stage, a team of 51–200 FTEs.
Education
MBA — Ravenscourt Institute (2004–2006)
Bachelor's degree — Beckford University